Respiratory Viruses: Differences in Who Gets Sickest


Respiratory viruses send patients of all ages to hospitals. A University of Massachusetts team analyzed exactly which viruses were most common and the degrees to which they made people ill.

Hospitals often get busy when community respiratory virus (CRV) infections spread. A Massachusetts team decided to compare the prevalence, morbidity and mortality of CRVs within the same population.

Reporting in a poster session at ID Week 2015 in San Diego, CA, Jamilah Shubeilat, MD and colleagues at the University of Massachusetts Medical School in Worcester, MA and colleagues reviewed the charts of 1,520 patients admitted from January 2010 to December 2013.

They looked at results from influenza antigen tests and multiplex nucleic acid amplification tests that can identify 12 viruses.

They found a single CRV infection caused 1,427 admissions, and 166 admissions with two or more concurrent CRVs.

Respiratory syncytial virus (RSV) was the predominant pathogen children under age 5 while influenza predominated in patients over 65.

The highest percentage of ICU admissions was seen with rhinovirus and human metapneumovirus.

In a related study done at the same institution, Aline Azar, MD, and colleagues reported on their use of multiplex nucleic acid amplification tests (MNAATs). The team looked at test results for 8,239 specimens where 51.6% were positive for at least one respiratory virus.

The analysis showed that seasonal variation was most common with flu, RSV and human metapneumovirus.

The researchers also found an unexpected difference in the frequency of infection by gender for some CRVs. Influenza A was more common in women and men were more likely to have parainfluenza 1, rhinovirus and adenovirus, “an observation which requires further investigation,” they concluded.

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.